News

AMRI Launches Stand-Alone Service; Expanding Solutions for Impurity Analysis and Toxicology Risk Assessment

2018-05-10T07:13:25+00:00

Company to extend its impurity assessments and control expertise to customers beyond offering as an accompanying service to support drug [...]

AMRI Launches Stand-Alone Service; Expanding Solutions for Impurity Analysis and Toxicology Risk Assessment 2018-05-10T07:13:25+00:00

AMRI’s Global Analytical Services Introduces Comprehensive Forced Degradation Services

2018-05-10T07:13:25+00:00

AMRI’s Global Analytical Services is pleased to launch a new comprehensive forced degradation service to meet the industry demand for supporting drug substance, product including medical devices, and associated packaging system development and commercialization.

AMRI’s Global Analytical Services Introduces Comprehensive Forced Degradation Services 2018-05-10T07:13:25+00:00

Whitehouse Laboratories To Participate On The Medical Device Reprocessing Panel Discussion At MD&M East

2018-05-10T07:13:26+00:00

MD&M East Schedule Whitehouse Laboratories is excited to announce that it has accepted an invitation to participate on the [...]

Whitehouse Laboratories To Participate On The Medical Device Reprocessing Panel Discussion At MD&M East 2018-05-10T07:13:26+00:00

What the Ever-Changing Revisions to USP <661> Really Mean & How the Industry is Responding

2018-05-10T07:13:26+00:00

John Iannone, Director, Extractables & Leachables (John.Iannone@amriglobal.com) Brandon Zurawlow, Associate Director, Container Qualification & CCIT (Brandon.Zurawlow@amriglobal.com) May, 2017 Recently, USP [...]

What the Ever-Changing Revisions to USP <661> Really Mean & How the Industry is Responding 2018-05-10T07:13:26+00:00